A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B

BACKGROUND: This study was performed to evaluate the effects and stability of the new hepatitis B immunoglobulin (HBIG), Hepabulin, in patients undergoing liver transplantation for hepatitis B. MATERIAL/METHODS: A total of 87 patients undergoing liver transplantation for hepatitis B-related liver di...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Ho Joong, Kim, Dong Goo, Kim, Soon Il, Wang, Hee Jung, Joh, Jae Won, Suh, Kyung Suk, Kim, Seong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248297/
https://www.ncbi.nlm.nih.gov/pubmed/29229898
http://dx.doi.org/10.12659/AOT.905898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248297/
https://www.ncbi.nlm.nih.gov/pubmed/29229898
http://dx.doi.org/10.12659/AOT.905898

Ejemplares similares